Pfizer, Moderna, Novavax: executives at several American laboratories developing COVID-19 vaccines have recently pocketed millions of dollars by selling shares in their companies—raising questions about the propriety of ...
Nov 15, 2020
0
14
To circumvent current tobacco advertising, promotion and sponsorship (TAPS) laws in Australia, tobacco companies are incentivising retailers with cash payments, all-expenses paid holidays, exclusive parties and tickets to ...
Sep 29, 2020
0
2
The largest ever survey on global public attitudes towards genomic research and data sharing suggests that work is needed to raise levels of public trust in how genetic data is used in order for that data to fulfil its promise ...
Sep 17, 2020
0
81
Allowing health data to flow more freely between countries in Europe could aid the fight against coronavirus while also help the region be better prepared for future pandemics, but privacy and technical considerations need ...
Sep 10, 2020
0
3
The act of giving and receiving increases well-being: the recipient benefits directly from the gift, and the giver benefits indirectly through emotional satisfaction. A new study published in the journal PNAS now suggests ...
Sep 01, 2020
1
314
Shares of German biotech company CureVac, which is developing a leading coronavirus vaccine candidate, rocketed Friday in its first day of trading in New York after raising more than $200 million in an initial public offering.
Aug 15, 2020
0
4
In an editorial for the journal Global Health Promotion, CUNY SPH Distinguished Professor Nicholas Freudenberg and Professor Kelley Lee of Simon Fraser University outline how shifting focus to the commercial determinants ...
Jul 15, 2020
0
0
The bad news, not that anyone needs more of it: The dangers of COVID-19 could worsen if misinformation on social media continues to spread unchecked. Essentially, what people choose to share on social media about the pandemic ...
Jul 02, 2020
0
26
British pharmaceuticals group AstraZeneca has approached US rival Gilead Sciences over a possible record merger, Bloomberg reported, as the pair spearhead treatments for COVID-19.
Jun 08, 2020
0
1
Unprecedented collaboration and resources will be required to research and develop safe and effective vaccines for COVID-19 that can be manufactured and delivered in the scale of billions of doses to people globally.
May 11, 2020
1
250
